|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
16933R-3 |
Symbol |
NLaz |
Full Name |
Neural Lazarillo |
CG No |
CG33126 |
Old CG No |
CG16933 |
Synonyms |
CT33980, CG16933, CG33126, BcDNA:RE67583, NLaz |
Accession No (Link to NCBI) |
NM_175946.1 |
Inserted Chr. |
lll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
Map Viewer |
|
Reference
[Please submit your publication]
|
Graca FA, Rai M, Hunt LC, Stephan A, Wang YD, Gordon B, Wang R, Quarato G, Xu B, Fan Y, Labelle M, Demontis F. The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy. Nat Commun (2022) 13(1) 2370
[
PubMed ID = 35501350
]
[
RRC reference
]
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgTCGAGTTCGCACCTGTTGCTG |
Primer Seq. 3' |
aatctagaggtaccTTTCTGGCCGCATCAACCGCT |
Predicted Fragment Size |
500 |
IR fragment full Seq |
0001 TCGAGTTCGC ACCTGTTGCT GCTTATCTCC GTGGTATTTG GGGCAGTATG GGTGGCCCAT
0061 TGCCCAGGTG CCATTTCCTG GCAAGTGCCC AGATGTTAAG CTACTGGACA CCTTCGACGC
0121 GGAAGCGTAT ATGGGCGTCT GGTACGAGTA CGCAGCCTAT CCATTTGCTT TCGAGATCGG
0181 CAAGAAGTGC ATCTACGCCA ACTACAGTCT CATAGACAAC AGCACTGTTT CGGTGGTGAA
0241 TGCGGCCATC AATCGATTCA CCGGACAACC CTCGAATGTA ACTGGACAGG CCAAGGTCCT
0301 TGGACCCGGT CAATTGGCCG TGGCCTTTTA CCCGACGCAG CCATTGACGA AGGCCAACTA
0361 CCTGGTTTTG GGCACAGATT ACGAGTCATA CGCCGTCGTC TACAGCTGCA CCAGTGTAAC
0421 ACCTTTGGCC AATTTCAAAA TTGTTTGGAT CTTGACTCGT CAGCGTGAAC CTTCAGCGGA
0481 AGCGGTTGAT gCGGCCAGAA A |
in silico PCR Fragment |
0001 TCGAGTTCGC ACCTGTTGCT GCTTATCTCC GTGGTATTTG GGGCAGTATG GGTGGCCCA-
0061 TGCCCAGGTG CCATTTCCTG GCAAGTGCCC AGATGTTAAG CTACTGGACA CCTTCGACGC
0121 GGAAGCGTAT ATGGGCGTCT GGTACGAGTA CGCAGCCTAT CCATTTGCTT TCGAGATCGG
0181 CAAGAAGTGC ATCTACGCCA ACTACAGTCT CATAGACAAC AGCACTGTTT CGGTGGTGAA
0241 TGCGGCCATC AATCGATTCA CCGGACAACC CTCGAATGTA ACTGGACAGG CCAAGGTCCT
0301 TGGACCCGGT CAATTGGCCG TGGCCTTTTA CCCGACGCAG CCATTGACGA AGGCCAACTA
0361 CCTGGTTTTG GGCACAGATT ACGAGTCATA CGCCGTCGTC TACAGCTGCA CCAGTGTAAC
0421 ACCTTTGGCC AATTTCAAAA TTGTTTGGAT CTTGACTCGT CAGCGTGAAC CTTCAGCGGA
0481 AGCGGTTGAT GCGGCCAGAA A |
Assemble Data |
16933R-3.IR_full 1 TCGAGTTCGCACCTGTTGCTGCTTATCTCCGTGGTATTTGGGGCAGTATGGGTGGCCCAT 60
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 1 TCGAGTTCGCACCTGTTGCTGCTTATCTCCGTGGTATTTGGGGCAGTATGGGTGGCCCA- 60
16933R-3.IR_full 61 TGCCCAGGTGCCATTTCCTGGCAAGTGCCCAGATGTTAAGCTACTGGACACCTTCGACGC 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 61 TGCCCAGGTGCCATTTCCTGGCAAGTGCCCAGATGTTAAGCTACTGGACACCTTCGACGC 120
16933R-3.IR_full 121 GGAAGCGTATATGGGCGTCTGGTACGAGTACGCAGCCTATCCATTTGCTTTCGAGATCGG 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 121 GGAAGCGTATATGGGCGTCTGGTACGAGTACGCAGCCTATCCATTTGCTTTCGAGATCGG 180
16933R-3.IR_full 181 CAAGAAGTGCATCTACGCCAACTACAGTCTCATAGACAACAGCACTGTTTCGGTGGTGAA 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 181 CAAGAAGTGCATCTACGCCAACTACAGTCTCATAGACAACAGCACTGTTTCGGTGGTGAA 240
16933R-3.IR_full 241 TGCGGCCATCAATCGATTCACCGGACAACCCTCGAATGTAACTGGACAGGCCAAGGTCCT 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 241 TGCGGCCATCAATCGATTCACCGGACAACCCTCGAATGTAACTGGACAGGCCAAGGTCCT 300
16933R-3.IR_full 301 TGGACCCGGTCAATTGGCCGTGGCCTTTTACCCGACGCAGCCATTGACGAAGGCCAACTA 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 301 TGGACCCGGTCAATTGGCCGTGGCCTTTTACCCGACGCAGCCATTGACGAAGGCCAACTA 360
16933R-3.IR_full 361 CCTGGTTTTGGGCACAGATTACGAGTCATACGCCGTCGTCTACAGCTGCACCAGTGTAAC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 361 CCTGGTTTTGGGCACAGATTACGAGTCATACGCCGTCGTCTACAGCTGCACCAGTGTAAC 420
16933R-3.IR_full 421 ACCTTTGGCCAATTTCAAAATTGTTTGGATCTTGACTCGTCAGCGTGAACCTTCAGCGGA 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16933R-3.in silico 421 ACCTTTGGCCAATTTCAAAATTGTTTGGATCTTGACTCGTCAGCGTGAACCTTCAGCGGA 480
16933R-3.IR_full 481 AGCGGTTGATGCGGCCAGAAA 501
|||||||||||||||||||||
16933R-3.in silico 481 AGCGGTTGATGCGGCCAGAAA 501
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_175946.1 |
CG33126-RA (NLaz), mRNA |
0.2 |
1 |
3 |
2 |
2 |
NM_132816.2 |
CG7872-RA (CG7872), mRNA |
0 |
0 |
2 |
3 |
4 |
NM_142606.2 |
CG10889-RA (CG10889), mRNA |
0 |
0 |
1 |
4 |
6 |
NM_135755.1 |
CG9932-RA (CG9932), mRNA |
0 |
0 |
1 |
3 |
5 |
NM_165580.2 |
CG8726-RA, transcript variant A (CG8726), mRNA |
0 |
0 |
1 |
3 |
5 |
NM_136497.3 |
CG8726-RB, transcript variant B (CG8726), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_167869.1 |
CG9184-RA, transcript variant A (CG9184), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_138255.1 |
CG9184-RB, transcript variant B (CG9184), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_140595.1 |
CG13054-RA (CG13054), mRNA |
0 |
0 |
1 |
2 |
2 |
NR_001733.1 |
CR30068, miscRNA |
0 |
0 |
1 |
2 |
2 |
NM_079184.3 |
CG14979-RA (Gr63a), mRNA |
0 |
0 |
0 |
8 |
3 |
NM_165024.1 |
CG31856-RA (CG31856), mRNA |
0 |
0 |
0 |
7 |
3 |
NM_079259.2 |
CG4974-RA (dally), mRNA |
0 |
0 |
0 |
5 |
7 |
NM_140327.1 |
CG10522-RA (sti), mRNA |
0 |
0 |
0 |
4 |
7 |
NM_057641.3 |
CG3052-RA (HLH4C), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_078769.2 |
CG11181-RA (cup), mRNA |
0 |
0 |
0 |
4 |
4 |
NM_143480.2 |
CG18041-RA (CG18041), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_001031989.2 |
CG33936-RC, transcript variant C (CG33936), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_001031991.2 |
CG33936-RA, transcript variant A (CG33936), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_001031990.2 |
CG33936-RB, transcript variant B (CG33936), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_001031988.2 |
CG33936-RD, transcript variant D (CG33936), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_139695.1 |
CG4597-RA (CG4597), mRNA |
0 |
0 |
0 |
3 |
6 |
NM_079308.2 |
CG18593-RA (viaf), mRNA |
0 |
0 |
0 |
3 |
5 |
NM_167487.1 |
CG32577-RA (disco-r), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_132897.1 |
CG4301-RA (CG4301), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_001043126.1 |
CG34158-RD, transcript variant D (SP2523), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_001043125.1 |
CG34158-RC, transcript variant C (SP2523), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_167985.1 |
CG14955-RB, transcript variant B (CG14955), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_139512.1 |
CG14955-RA, transcript variant A (CG14955), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_169206.1 |
CG9656-RA (grn), mRNA |
|
|
|